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Abstract
Background: We used structural equation modeling to evaluate the quality of life (QOL) for patients with Marfan
syndrome (MFS). The goal was to provide guidelines to facilitate the development of interventions and strategies to
improve the QOL for patients with MFS.
Methods: The participants fulfilled the Ghent 2 criteria for MFS and they comprised patients who visited the cardiology
outpatient department of a tertiary hospital in Seoul, Korea, between August 17, 2013 and April 17, 2014. Demographic,
social support, disease-related factors, biobehavioral factors, and QOL data were collected in one-on-one interviews.
Results: The final analyses included 218 patients. Anxious and depressed patients comprised 63.8 and 71.5 % of
the sample, respectively. For the hypothetical model, the goodness-of-fit index = 0.91, normal fit index = 0.93, and
comparative fit index = 0.90. The outcome was suitable for the recommended level, so the hypothetical model
appeared to fit the data. In patients with MFS, the QOL was affected significantly by social support, disease-related
factors, and biobehavioral factors. These variables explained 72.4 % of the QOL in patients with MFS. Biobehavioral
factors had the strongest and most direct effects on QOL.
Conclusion: To improve QOL in patients with MFS, comprehensive interventions are necessary to assess and manage
biobehavioral factors, social support, and disease-related factors.
Background
Marfan syndrome (MFS) is a genetic disease caused by
a mutation in the fibrillin-1 gene, which controls a
component of connective tissue [1]. The average life ex-
pectancy of individuals with MFS has been extended
and it is similar to that of healthy people when patients
receive appropriate interventions, such as the adminis-
tration of beta-blockers, restrictions on physical activ-
ity, and aortic surgery [2].
These medical treatments have improved the survival
rate and health status of patients with MFS [3]. However,
patients with MFS are still susceptible to sudden death
with aortic dissection or rupture, which may occur at any
time in their lives [1]. In addition, patients with MFS may
experience the burden of numerous instances of vascular
surgery, the administration of medication throughout the
lives, restricted physical activity, pain, and chronic fatigue
[3–5]. There is a >50 % possibility of the disease being
transmitted to the children of patients with MFS [6] and
they have distinct physical characteristics [7, 8]. All of
these issues result in emotional distress in patients with
MFS, including anxiety and depression [3–9]. Most pa-
tients with MFS suffer from physical and psychological
issues throughout their lives [4, 10]. Therefore, it is ne-
cessary to consider physical and psychological aspects
when assessing the overall quality of life (QOL) in pa-
tients with MFS.
According to previous studies, the main factors that in-
fluence that QOL in patients with MFS comprise MFS-
related physical symptoms, anxiety, depression, and social
support [3–12]. However, VanToerloo and De Paepe
found that the incidence of depression and anxiety by pa-
tients with MFS did not differ significantly from that in
the normal population [10]. In addition, most previous
studies investigated the impacts of single factors on the
QOL of individuals with MFS, but various factors can
affect the QOL in multifaceted ways, both directly and in-
directly. Previous studies have reported that demographic
factors [5, 9, 13] and disease-related physical symptoms
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[3, 5, 8, 11, 12] (e.g., aortic proximal dilatation and clinical
symptoms) influence the QOL, but they also affect the
prevalence of QOL-related factors such as depression and
fatigue [5, 14, 15]. Moreover, these studies found that pain
[3, 14], fatigue [3, 5, 14, 15], and body image [3, 7] were
related to the QOL of individuals with MFS, as well as the
variables that influence depression and anxiety. These bio-
behavioral factors, including anxiety, depression, fatigue,
pain, and body image, combined with social support
will have complex effects on the QOL of patients with
MFS [4, 16, 17].
However, no previous studies have constructed or veri-
fied a comprehensive structural model of the relation-
ships among the various factors that may affect the QOL
of patients with MFS, including biobehavioral factors, to
identify the direct or indirect relationships among these
factors. In particular, there is a need for a QOL model of
patients with MFS in Korea because the social, cultural,
and physical characteristics of these patients may differ
from those in other countries, as described in previous
studies. In addition, structural model validation is re-
quired to establish a strategic plan for improving the
QOL of patients with MFS.
Purpose
The aim of this study was to build a QOL structural
model of patients with MFS, verify its goodness of fit,
and determine the factors that affect the QOL, as well
as their direct or indirect relationships. After detect the
QOL status, they may be considered about this prob-
lems and advice to helping about their specific issues.
Conceptual framework and hypothetical research
model
Based on a literature review and previous studies, we
determined that demographic factors, social support,
disease-related factors, and biobehavioral factors affect
the QOL of patients with MFS directly or indirectly.




We developed an exploratory structural model study to
identify the factors that affect the QOL of patients with
MFS. We then examined the direct and indirect relation-
ships among these factors.
Research subjects
The inclusion criteria comprised adult patients aged
≥20 years who were diagnosed with MFS based on the re-
vised Ghent guidelines [1]. The exclusion criteria com-
prised patients with a history of psychiatric disorder, such
as schizophrenia or bipolar disorder, and organic psychotic
symptoms, or who had taken prescribed psychotic drugs,
such as antidepressants, for more than two weeks. The
study period ranged from August 17, 2013 to April 20,
2014. In total, 239 patients visited the Samsung Medical
Center MFS Clinic during this period. We excluded 21 pa-
tients, i.e., 16 because they had taken antidepressants for
more than two weeks or they had been diagnosed with
schizophrenia or bipolar disorder, and five because they
responded inadequately to the survey questions. Thus, the
final analysis included 218 patients. The sample size
Fig. 1 Research framework. FH of MFS = family history of Marfan syndrome; Ao = sinus of Valsalva of diameter Z (= Z score), indicating the
presence of aortic root dilatation (when standardized with respect to age and body size); FEN 1 = fibrillin-1 mutation; EL = ectopia lentis; OP of
CV = operation on the cardiovascular system
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satisfied the requirements for structural equation modeling
analysis (i.e., a sample size ≥200) [18, 19].
Instruments
QOL
QOL was measured with the Korean version of the 36-
item Short-Form Health Survey (SF-36), which was devel-
oped by Ware and Sherboune [20, 21]. It was translated
into the Korean version and tested by Nam and Lee [22].
The SF-36 questionnaire was designed to measure eight
health concepts: limitations on physical activities and the
usual roles of activities due to physical health problems;
limitations on social activities because of physical or emo-
tional problems; general mental health (psychological dis-
tress and well-being); bodily pain; limitations on the usual
roles of activities due to emotional problems; vitality (en-
ergy and fatigue); and general health perception. The
items from each concept were summed and rescaled over
a range of 0–100, where 100 represented the best health-
related QOL. The scores on the subscales were aggregated
into two standardized summary scores: physical compo-
nent summary (PCS) and mental component summary
(MCS) [20, 21]. Quality Metric Health Outcome Scoring
Software 4.5 was used to calculate the QOL scores in the
present study [23]. The Korean version of SF-36 has ad-
equate internal consistency (0.92–0.94), test/retest reliabil-
ity (0.71–0.89), and construct validity [24]. In this study,
Cronbach’s α for the SF-36 was 0.89 based on the total
score, with 0.88 for PCS and 0.91 for MCS.
Social support
Social support was evaluated using the Multidimensional
Scale of Perceived Social Support (MSPSS) tool, which
was developed by Zimet et al. [25] and a version was
translated into Korean by Shin and Lee [26]. The MSPSS
tool comprises 12 items and uses a five-point scale to as-
sess family support, friend support, and special support.
The possible score ranges among 12–60 points, where
higher scores represent better social support. Cronbach’s
α for the reliability of the original tool was 0.83 [25] and
0.89 in the present study. Cronbach’s α for family sup-
port, friend support, and special support were 0.93, 0.87,
and 0.89, respectively.
Disease-related factors
Disease-related factors are components of the revised
Ghent nosology [1]. They comprise the diameter of the
sinus of Valsalva according to echocardiography, the
presence or absence of the fibrillin-1 mutation based
on genetic analysis, intraocular lens dislocation, the
number of thoracic and abdominal aortic surgeries, and
the presence/absence of a family history of MFS.
Biobehavioral factors
Biobehavioral factors are personal responses to a disease,
which include emotional and physiological processes
[27, 28]. In this study, these factors comprised depression,
anxiety, fatigue, pain, and body image. These biobehav-
ioral factors were identified based on previous studies,
which demonstrated that pain [3, 14], fatigue [3, 5, 14, 15],
body image [3, 7], and anxiety and depression have signifi-
cant relationships with each other [27, 28].
1. Anxiety and depression: Anxiety and depression
were measured with the Hospital Anxiety
Depression scale of Korea (HAD-K), which was
developed by Zigmond and Snaith [29] and
translated into Korean by Oh et al. [30] The HAD-K
comprises 14 questions, where even numbers are
questions related to depression and odd numbers
address anxiety. Each question is assessed on a four-
point scale, where a total score of <8 points denotes
no depression/anxiety, 8–10 points denote border-
line depression/anxiety, and >11 points signifies clin-
ical depression/anxiety [29]. For the original tool,
Cronbach’s α was 0.89 for depression and 0.79 for
anxiety [29], whereas in this study, the values were
0.82 for depression and 0.85 for anxiety.
2. Fatigue: Fatigue was measured with the Fatigue
Severity Scale, which was developed by Krupp et al.
[31] and translated into Korean by Kim [27]. The
possible scores range among 9–63 where a higher
score indicates a more severe degree of fatigue.
3. Pain: We used a 10-cm visual analog scale (VAS) to
assess pain. The left-hand side of the VAS was re-
corded as no pain whereas the most severe pain was
recorded at the end of the right-hand side. Chest
pain, back pain, and muscle pain were assessed and
recorded during the previous four weeks.
4. Body image: Body image was measured using the
Body Image States Scale (BISS) developed by Cash
et al. [32]. Permission was obtained from the
authors to translate the BISS into a Korean version
for this study. The translation was processed
according to Brislin’s translation model [33]. The
BISS comprises six questions about physical
appearance and it utilizes a nine-point scale. Reverse
scoring was used to score the even numbered ques-
tions. The total possible score ranged among 6–63
points where a higher score denoted a more positive
body image. Cronbach’s α for the original tool was
0.85 [32] and it was 0.83 in the present study.
Data collection
To protect the subjects, the survey was conducted after
obtaining approval (no. 2013–08–016) from the Institu-
tional Review Board of the Samsung Medical Center. If
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the subjects agreed to participate in the study, they were
asked to sign a consent form and to complete a ques-
tionnaire. One researcher and a cardiovascular center
outpatient nurse who served as a research assistant col-
lected the survey data during one-on-one interviews
when the patient visited the outpatient clinic for check-
ups or tests. Before collecting the data, the chief of re-
search met with the research assistant three times to
discuss the purpose and risks of the study, ethical as-
pects related to patients, and the survey tools used for
data collection. To ensure the consistency of the re-
search methods between interviewers, the interviews
were performed together for the first five patients before
subsequent data collection. After the data collection
process commenced, the researcher and the research as-
sistant had a consultation meeting each week to discuss
any issues that emerged during the interviews. The re-
searcher reviewed the medical records and collected the
patient’s clinical information.
Statistical analysis
The data were analyzed using SPSS (v. 21.0) and AMOS
(v. 21.0) software. Descriptive statistics were used to
analyze demographic factors, social support, physical
factors, biobehavioral factors, and the QOL of patients
with MFS. Pearson’s correlation coefficient was used to
determine the multicollinearity between the variables.
The generalized least squares method was used because
the model satisfied normality for kurtosis and skewness,
but it did not satisfy multivariate normality. The following
were used in the goodness-of-fit tests for the model: χ2,
degrees of freedom (df), goodness-of-fit index (GFI), nor-
mal fit index (NFI), comparative fit index (CFI), root mean
squared error of approximation (RMSEA), Tucker–Lewis




In total, 137 (62.8 %) of the patients were men and the
mean age was 36.3 ± 4.5 years. Among the patients, 166
(76.2) were college graduates, 150 (69.2) were employed,
and 145 (66.5 %) were married. The mean height of the
patients was 178.4 ± 12.5 cm. After standardizing for age
and weight, 167 (76.6) patients had an abnormally dilated
aorta and 99 (45.2 %) patients possessed the fibrillin-1
mutation according to genetic tests. In addition, 163
(74.8) patients had past medical history of more than one
cardiovascular surgery and 79 (36.2 %) had a family his-
tory of MFS (Table 1).
Descriptive statistics
The mean, standard deviation, and ranges of the vari-
ables used in this research model are shown in Table 2.
The kurtosis and skewness values for all of the variables
used in this study were less than ±1.96 (Table 2) and the
assumption of a normal distribution was satisfied [10, 12].
Correlation and multicollinearity analysis of the variables
Before hypothesis testing, we conducted correlation ana-
lysis using the measured variables. Lower QOL was associ-
ated with older age (r = −0.25, P = 0.013), lower educational
level (r = 0.42, P = 0.012), lower economic status (r = −0.15,
P = 0.024), lower social support (r = 0.49, P < 0.001),
increased number of cardiovascular surgeries (r = −0.56,
P < 0.001), increased anxiety (r = −0.59, P < 0.001), increased
depression (r = −0.67, P < 0.001), greater fatigue (r = −0.52,
P < 0.001), higher pain scores (r = −0.64, P < 0.001), and
lower body image (r = 0.50, P < 0.001). The absolute values
of the correlation coefficients determined between the pairs
of independent variables were all <0.70. Therefore, multi-
collinearity was not present in the data [18, 19].
Table 1 Demographic & clinical characteristics of subjects
(N = 218)
Characteristics Categories N (%) or
Mean ± SD
Range
Gender Male 137 (62.8)
Female 81 (37.2)
Age (year) 36.3 ± 4.5 18–62
Male 37.5 ± 5.7 18–57
Female 35.1 ± 3.4 20–62
Education level High school 52 (23.8)
≥ College 166 (76.2)
Occupation Yes 150 (69.2)







< 120 38 (17.5)
120–319 114 (52.3)
≥ 320 66 (30.2)
Height(cm) 178.4 ± 12.5 156.3–192.6
Ao.(Z > 2)a Yes 167 (76.6)









Family history of MFSb Yes 79 (36.2)
The values are expressed as mean ± standard deviation; and qualitative
variables, as percentages of the total. aAo sinus of Valsalva of diameter, Z Z
score, the presence of aortic root dilatation (when standardized to age and
body size); MFSb = Marfan syndrome
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Testing the structural model of the QOL of patients
with MFS
Feasibility assessment for the hypothetical model
We conducted a confirmatory factor analysis of the meas-
urement model in step 1. The confirmatory factor analysis
was performed with demographic factors, social support,
disease-related factors, biobehavioral factors, and QOL,
whereas we excluded single measurement latent variables.
Based on the disease-related factors, the factor loading for
crystalline lens dislocation was 0.09, which was below the
reference value range of 0.5–0.95. Thus, this factor was re-
moved because of its poor fit with the measurement
model [18, 19].
Test of the goodness of fit of the hypothetical model
The results of the analysis of the structural equation
model produced using the study variables in the hypothet-
ical model were as follows: goodness of fit for χ2 = 151.30
(P < 0.001, df = 45), GFI = 0.91, RMSEA = 0.05, NFI = 0.93,
CFI = 0.92, TLI = 0.97, PGFNI = 0.46, and PNFI = 0.44. All
of the GFI indices satisfied the recommended levels.
Analysis of the hypothetical model
The results of the analysis of the hypothetical model are
as follows (Fig. 2). In the hypothetical model, the following
were statistically significant: disease-related factor path in
the demographic factors (P < 0.001), biobehavioral factor
path in the demographic factors (P < 0.001), biobehavioral
factor path in the social support path (P < 0.001), QOL
path in the social support path (P < 0.05), QOL path in the
disease-related factor path (P < 0.001), biobehavioral factor
path in the disease-related factor path (P < 0.001), and
QOL path in the biobehavioral factor path (P < 0.001).
However, the QOL path (P = 0.432) was not statistically
significant in the demographic factors. The modification
indices for the other paths were all <10.0 and none of the
paths required further analysis.
Effectiveness analysis of the hypothetical model
The direct, indirect, and total effects of the factors associ-
ated with the QOL of the patients with MFS are presented
in Table 3. The biobehavioral factors had the greatest direct
effect on the QOL with a score of 0.695. The disease-
related factors had a direct effect on the QOL with a path
coefficient of 0.391, and a total effect of −0.091 when added
to the indirect effect of the biobehavioral factors (0.300).
Social support had a total effect of 0.172 on the QOL.
Social support, disease-related factors, and biobehavioral
factors explained 72.4 % of the QOL of the patients with
MFS. Demographic factors, social support, and disease-
related factors explained 52.2 % of the QOL. Demographic
factors also explained 12.4 % of the disease-related factors.
Discussion
In this study, we aimed to construct a hypothetical model
and verify the significance of the direct/indirect paths and
the goodness of fit of the model under the theoretical
assumption that demographic factors, social support,
disease-related factors, and biobehavioral factors, including
depression, anxiety, fatigue, pain, and body image, deter-
mine the QOL of patients with MFS directly and indirectly.
This study is significant because it is the first analysis of
the QOL of patients with MFS in Korea.
According to this structural model, social support,
disease-related factors, and biobehavioral factors explained
72.4 % of the QOL for MFS subjects. Direct comparisons
with the findings of other studies are difficult because
there are no other comprehensive QOL models of patients
with MFS, or alternative hereditary diseases, from Korea
or other countries. However, although the patient group
was different, a structural model that targeted patients
with osteoarthritis [34] had explanatory power of more
than 63.6 %. This difference may be attributed to the in-
clusion of biobehavioral-related factors in the present
study, whereas the other study focused only on the phys-
ical and psychological adaptation of patients with degen-
erative arthritis. Studies of Korean stroke patients [35] and
chronic kidney failure patients [27] have found that de-
pression, anxiety, fatigue, and pain affect the QOL of pa-
tients, thereby demonstrating that biobehavioral factors
have a significant impact on QOL in patients. In previous
studies, anxiety and depression were the most important
biobehavioral factors in patients with MFS [3–7].
Studies have shown that pain [3, 14] caused by dural
ectasia and surgery, fatigue [3, 5, 14, 15], and body image
Table 2 Descriptive statistics and test for normality of observed
variables (N = 218)
Variables N (%) or
Mean ± SD
Range Skewness Kurtosis
Social support 41.3 ± 8.5 19.1–55.6 -.11 .07








Fatigue 46.3 ± 6.5 30.2–59.1 .13 .28
Pain 6.9 ± 2.3 4.2–8.5 1.04 -.72
Body image 15.2 ± 5.6 9.6–25.1 -.01 -.75
Quality of life 42.8 ± 10.3 22.2–86.2 .18 .30
Multivariate 18.96
The values are expressed as mean ± standard deviation; and qualitative
variables, as percentages of the total
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issues [3, 7], such as great height, long and thin fingers,
scoliosis, and the need for thick eyeglasses, were associ-
ated with depression, anxiety, and QOL. Depression, anx-
iety, pain, fatigue, and the body image of patients with
MFS could influence the QOL either independently or in
complex combinations. Previous studies have shown that
each of these variables affects the QOL of patients with
MFS independently [4, 9], but no studies have examined
the comprehensive effects of all of these variables on the
QOL. In this study, we defined depression, anxiety, fa-
tigue, pain, and body image as biobehavioral factor vari-
ables that affect patients with MFS, and we analyzed the
paths and the degrees of these factors with respect to
QOL in patients.
Confirmatory factor analysis of each of the biobehav-
ioral factors showed that all the variables had a loading
of >0.70, which indicated that it was reasonable to group
them into biobehavioral factors. According to the results
of this study where we defined depression as a biobehav-
ioral factor, 98.2 % of the patients were found to have
depression, including borderline depression, which dem-
onstrates that most patients with MFS experienced de-
pression. These results are partly consistent with those
reported by Fusar-Poli et al. [9] who found that depres-
sion and schizophrenia were prevalent among patients
with MFS due to the possibility of sudden death caused
by aortic rupture, in addition to limitations in terms of
physical activity and exercise, the need for lifelong medi-
cation, and a high risk of second-generation heritability.
However, this was a high rate of experience of depres-
sion compared with the results reported by Peter et al.
[4] who found that only 46 % experienced depression
using the Center for Epidemiological Studies Depression
Scale. Moreover, the study by Peter et al. [4] used
Fig. 2 Path diagram for the hypothetical model. *P < 0.05; **P < 0.01. x1 = Age; x2 = Education level; x3 = Economic status; x4 = Family support;
x5 = Friend support; x6 = Special support; y1 = Dilatation of sinus of Valsalva; y2 = Fibrillin-1 mutation; y3 = Family history of Marfan syndrome;
y4 = Frequency of operations on the cardiovascular system; y5 = Anxiety; y6 = Depression; y7 = Fatigue; y8 = Pain; y9 = Body image; y10 = Physical
component score; y11 =Mental component score
Table 3 Standard direct, indirect and total effect







Quality of life Demographic factors -.172 -.182 .354 .724
Social support .193* .173 .366
Disease-related factors -.391** -.196 .587
Biobehavior factors -.695** -.695
Bio-behavior factors Demographic factors -.220** -.203 -.423 .522
Social support .313** .313
Disease-related factors .433** .433
Disease-related factors Demographic factors -.221** -.221 .124
SMC Squared multiple correlations
*P < .05; **P < .01
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different tools so it was difficult to compare their results
with those obtained in the present study, which may also
be attributable to differences among the participants. In
particular, the participants in the present study were
fairly young and they comprised a higher number of
males than females, where most had a high education
level. These factors may have affected the reported ex-
perience of depression. This is partially supported by the
findings of Fusar-Poli et al. [9] who reported that older
patients and male patients had poor mental well-being.
The results of the latter study showed that 93 % of the pa-
tients had both depression and anxiety; indeed, anxiety
and depression are strongly related. In addition, age, edu-
cational level, economic condition, social support, number
of surgeries, and the presence/absence of a family history
of the disease were associated with anxiety and depression
according to the additional analysis performed in this
study. Depression and anxiety are significantly associated
with perceived stigma [7] and coping strategies [7, 9], but
this area still requires further research.
Furthermore, the analysis of our structural model
showed that biobehavioral factors had direct effects on the
QOL, but there were also important roles for demo-
graphic characteristics, social support, and disease-related
factors. Therefore, the results of this study demonstrate
that multifaceted elements, including biobehavioral fac-
tors, are important variables for explaining the QOL of
patients with MFS. Moreover, this study highlights the im-
portance of biobehavioral factors and the need for biobe-
havioral interventions to address clinical care issues [30].
Among the variables, we found that disease-related
factors had the greatest impact on biobehavioral factors.
We selected the main disease-related factors based on
the guidelines in the Ghent criteria, which are used to
diagnose MFS. The Ghent criteria comprise aortic dila-
tation, the presence of a mutation in the fibrillin-1 gene
according to genetic tests, and the presence/absence of a
family history of the disease [1]. The number of surger-
ies was added to these factors in our study. Our findings
confirm that QOL, in addition to depression and fatigue
[3, 5], is related to aortic proximal dilatation and a defin-
ite diagnosis by genetic testing [36, 37]. Biobehavioral
changes are likely to occur in patients with gradually
progressive aortic dilatation who have been diagnosed by
genetic testing and who have undergone multiple cardio-
vascular operations. These patients require special atten-
tion and care.
The results of this study also demonstrate that social
support influenced biobehavioral factors. When we ana-
lyzed the association between social support, biobehavioral
factors, and depression, we found that social support had a
significant influence on depression. These results are con-
sistent with those obtained by Cohen and Biesecker who
described the role of social support in depression [16]. In
addition, we separately analyzed the level of support per-
ceived by the patient, which showed that support from the
nurse, spouse, and family were the only support factors
that decreased depression in patients. This is mainly attrib-
utable to the cultural characteristics of Korea, which places
a great emphasis on blood ties.
Based on these results, approaches should be developed
for effectively managing biobehavioral factors, including
anxiety, depression, fatigue, pain, and body image, to im-
prove the QOL of patients with MFS. These approaches
could enhance the QOL because biobehavioral factors
may be adjusted to manage patients by considering the
progression of aortic dilation, the identification of MFS
genes, the number of cardiovascular surgeries, and the
presence or absence of a family history as disease-
related factors.
Thus, QOL may be improved by managing biobehavioral
factors, which are influenced by disease-related factors, the
progression of aortic dilation, and the identification of
MFS genes, the number of cardiovascular surgeries, and
the presence or absence of a family history. Developing
and providing intervention programs to enhance social
support may reduce biobehavioral changes, such as depres-
sion, which may be a good strategy for improving the QOL
of patients with MFS.
Our investigation differs from previous studies be-
cause we considered the QOL of Korean patients with
MFS for the first time. Furthermore, this is the first
study in Korea or other countries to show that multiple
variables (i.e., social support, disease-related factors,
and biobehavioral factors) can affect the QOL of pa-
tients with MFS.
A limitation is that this was a single study where
62.8 % of the patients were male, relatively young, and
highly educated. The participants were patients with
mild MFS who could visit outpatient clinics and those
with severe depression who had difficulty visiting out-
patient clinics were not included. Thus, the results of
the study must be generalized with care. In addition, we
did not use a disease-specific QOL tool that was devel-
oped for patients with MFS. The reliability and validity
of the tool that we employed was verified previously in a
healthy population and it is applied widely to chronic
disease patients rather than those specifically with MFS.
The reliability of this tool was satisfactory in the present
study, but we suggest that follow-up studies should be
performed to develop and apply a disease-specific QOL
tool for patients with MFS.
Conclusion
In this study, we analyzed the factors that affect the
QOL of patients with MFS and we constructed a model
to identify direct and indirect paths. All of the GFI indi-
ces satisfied the recommended levels.
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According to this structural model, social support,
disease-related factors, and biobehavioral factors ex-
plained 72.4 % of the QOL for MFS subjects. Biobehav-
ioral factors explained 39.2 % of the social support and
disease-related factors. In addition, demographical fac-
tors explained 12.4 % of the disease-related factors.
Based on these results, approaches should be developed
for effectively managing biobehavioral factors to improve
the QOL of patients with MFS. These approaches could
enhance the QOL because biobehavioral factors may be
adjusted to manage patients by considering disease-
related factors.
Developing and providing intervention programs to en-
hance social support may reduce biobehavioral changes,
such as depression, which may be a good strategy for im-
proving the QOL of patients with MFS.
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